Biotronik receives CE Mark approval for new Edora pacemakers

Biotronik has announced that its new Edora pacemakers and cardiac resynchronisation therapy pacemakers.

These new devices incorporate Biotronik's ProMRI technology, including the MRI AutoDetect sensor, meaning they are able to automatically adapt to magnetic resonance imaging (MRI) environments.

With this approval, the company now offers the industry's first full portfolio of cardiac devices with MRI sensors. When the sensor is activated, the device is calibrated to automatically adapt to an MRI environment, maintaining full functionality until the scan is performed. This can take place up to 14 days after the physician turns the sensor on.

The small-sized Edora pacemakers also expected to have more than 14 years of longevity, meaning the devices offer a broad range of advantages.

Manuel Ortega, senior vice-president at Biotronik, said: "With Home Monitoring and the Closed Loop Stimulation algorithm also onboard, we're proud to be able to give all patients, whatever device they need, the very best care possible."

The MRI AutoDetect feature recently won the Cardiostim Innovation Award for best practice improvement, recognising the benefits the technology can deliver in terms of patient safety and physician workflows.